Netilmicin pharmacokinetics in Hong Kong Chinese cancer patients

British Journal of Clinical Pharmacology

Volumn 48, Issue 1, 1999, Pages 33-35

  Chang, Sophie ^a   Li, Ronald C ^a   Chan, Lesley S Y ^a   Wong, S Y ^a   Zhu, Min ^a   Chan, Anthony T C ^a   Raymond, Kenneth ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer patients; Chinese; Netilmicin; Pharmacokinetics

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; NETILMICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHINESE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; FEMALE; HONG KONG; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENTAMICINS; HONG KONG; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NETILMICIN; PROSPECTIVE STUDIES;

EID: 0033058589     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00955.x     Document Type: Article

References (9)

1. 1 Weaver, RH, Cipolle, RJ. Improved aminoglycoside therapy: clinical application of pharmacokinetoc principles. In Applied Clinical Pharmacokinetics, ed Mungall DR. 1st edn. New York: Raven Press, 1983: 153-85.
2. 2 Segal, JL, Gray, DR, Gordon SK, et al. Pharmacokinetics of gentamicin in patients with spinal cord injury. Clin Pharm 1984; 3: 418-20.
3. 3 Gardner, DK, Schneider, PJ. Gentamicin dosage requirements in postpartum patients. Clin Pharm 1984; 3: 416-8.
4. 4 Marik, PE. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care 1993; 21: 172-3.
5. 5 Manny, RP, Hutson, PR. Aminoglycoside volume of distribution in hematology-oncology patients. Clin Pharm 1986; 5: 629-32.
6. 6 Higa, GM, Murray, WE. Alterations in aminoglycoside pharmacokinetics in patients with cancer. Clin Pharm 1987; 6: 963-9.
7. 7 Kaojarern, S, Maoleckoonpairoj, S, Atichartakam, V. Pharmacokinetics of amikacin in hematologic malignancies. Antimicrob Agents Chemother 1989; 33: 1406-8.
8. 8 Davis, RL, Lehmann, D, Stidley, CA, et al. Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy. Antimicrob Agents Chemother 1991; 35: 944-7.
9. 9 Zeitany, RG, El Saghir, NS, Santhosh-Kumar, R, et al. Increased aminoglycoside dosage requirements in hematologic malignancy. Antimicrob Agents Chemother 1990; 34: 702-8.